News Takeda to buy stem cell specialists TiGenix for $626m Decision follows EU regulators' decision to back Crohn's stem cell therapy
News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros
News Gilead could make a move for Galapagos within weeks The share price of Belgium-Dutch biotech Galapagos is rising thanks to renewed speculation that Gilead may be poised to acquire it.
News After more encouraging data, Ablynx to file first drug with ... New trial data will be included in US and EU filings
Views & Analysis How can the UK improve in clinical research? A biotech persp... The UK is a great place for early-stage research – but NHS red tape and market access remain major barriers.
News Apitope announces IPO to fund MS drug development Biotech Apitope plans to float on the Brussels stock exchange to raise funds to develop a potential new MS drug.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
